Patents-Review.com
ClassID:

21038 ⎘

A61K38/486 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on peptide bonds (3.4); Serine endopeptidases (3.4.21) Elastase (3.4.21.36 or 3.4.21.37)

Recent Application in this class:
#1
20260069665
2026-03-12

SYSTEMS AND METHODS FOR EPICARDIAL TISSUE DISTENSION SOLUTIONS

 #2
20230056486
2023-02-23

METHODS OF TREATING NEUROLOGICAL DISORDERS

 #3
20230041686
2023-02-09

Method for Producing Peptide Ace Inhibitors

 #4
20220218639
2022-07-14

TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS

 #5
20220000977
2022-01-06

METHODS AND COMPOSITIONS RELATED TO THERAPEUTIC PEPTIDES FOR CANCER THERAPY

 #6
20210154276
2021-05-27

Methods of treating neurological disorders

 #7
20210145944
2021-05-20

Methods of treating neurological disorders

 #8
20210115426
2021-04-22

Peptide therapeutics for treating Alzheimer's disease and related conditions

 #9
20200261386
2020-08-20

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

 #10
20200208132
2020-07-02

RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF

 #11
20190262436
2019-08-29

Method for producing peptide ACE inhibitors

 #12
20190183989
2019-06-20

Use of serine protease inhibitors in the treatment of skin diseases

 #13
20190142780
2019-05-16

Use of isothiocyanate compounds

 #14
20190062718
2019-02-28

RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF

 #15
20190010476
2019-01-10

Recombinant Elastase Proteins and Methods of Manufacturing and Use Thereof

 #16
20180273928
2018-09-27

RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF

 #17
20180208918
2018-07-26

Nucleic acid molecules encoding autoactivating type I pancreatic proelastase proteins

 #18
20180155703
2018-06-07

Recombinant elastase proteins and methods of manufacturing and use thereof

 #19
20170189362
2017-07-06

Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis

 #20
20170028037
2017-02-02

Reduced-pressure treatment systems and methods employing debridement mechanisms

 #21
20160243205
2016-08-25

RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF

 #22
20160015745
2016-01-21

Formulations of Antimicrobial, Antiviral, and Antineoplastic Compounds In Combination With Certain Wavelengths of Light

 #23
20150086565
2015-03-26

Cancer-related extracellular matrix signatures and related methods and products

 #24
20150037294
2015-02-05

Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell1

 #25
20140341881
2014-11-20

USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES

 #26
20140004098
2014-01-02

Methods of treatment with elastase

 #27
20120220925
2012-08-30

Reduced-pressure treatment systems and methods employing debridement mechanisms

 #28
20120220924
2012-08-30

Reduced-pressure treatment systems and methods employing debridement mechanisms

 #29
20110250186
2011-10-13

Methods for promoting wound healing and muscle regeneration with the cell signaling protein Nell1

 #30
20110182876
2011-07-28

Methods of prolonging patency of hemodialysis access

 #31
20110130338
2011-06-02

USE OF SERINE PROTEASE INHIBITORS IN THE TREATMENT OF SKIN DISEASES

 #32
20110081705
2011-04-07

RECOMBINANT ELASTASE PROTEINS AND METHODS OF MANUFACTURING AND USE THEREOF

 #33
20110008315
2011-01-13

Recombinant elastase proteins and methods of manufacturing and use thereof

 #34
20100203034
2010-08-12

Methods for the treatment and prevention of diseases of biological conduits

 #35
20100160871
2010-06-24

Reduced-pressure treatment systems and methods employing debridement mechanisms

 #36
20100143289
2010-06-10

UMBILICAL CORD STEM CELL SECRETED PRODUCT DERIVED TOPICAL COMPOSITIONS AND METHODS OF USE THEREOF

 #37
20100130415
2010-05-27

Stem cell secreted product derived compositions for wound treatment

 #38
20090208474
2009-08-20

BIOLOGICAL ENTITIES AND THE USE THEREOF

 #39
20090208440
2009-08-20

BIOLOGICAL ENTITIES AND THE USE THEREOF

 #40
20090196865
2009-08-06

Methods for the treatment and prevention of diseases of biological conduits

 #41
20090162343
2009-06-25

Recombinant elastase proteins and methods of manufacturing and use thereof

 #42
20090142312
2009-06-04

Methods for promoting wound healing and muscle regeneration with the cell signaling protein Nell1

 #43
20090060897
2009-03-05

System comprising elastase

 #44
20090060893
2009-03-05

Methods for enlarging the lumen of an obstructed biological conduit

 #45
20090041738
2009-02-12

Method for treating a pulmonary disease state in mammals by up regulating indigenous in vivo levels of inflammatory agents in mammalian cells

 #46
20080317736
2008-12-25

Methods for enlarging the diameter of a biological conduit in a human subject

 #47
20070141042
2007-06-21

Methods for the treatment and prevention of diseases of biological conduits

 #48
20070014782
2007-01-18

Kit comprising elastase

 #49
20070014781
2007-01-18

Methods for using an elastase

 #50
20060193824
2006-08-31

Methods for the treatment of infectious and inflammatory airway diseases

 #51
20050244401
2005-11-03

Compositions and methods for reducing lung volume

 #52
20050175581
2005-08-11

Biological entities and the pharmaceutical and diagnostic use thereof

 #53
20050069532
2005-03-31

Treatment of bacterial infection with elastase

 #54
20050059126
2005-03-17

Engineered enzymes and uses thereof

 #55
20050025722
2005-02-03

Removing dental plaque with krill enzymes

 #56
20050002897
2005-01-06

Biological entities and the pharmaceutical or diagnostic use thereof